Post-streptococcal glomerulonephritis primary prevention: Difference between revisions
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
==Primary Prevention== | ==Primary Prevention== | ||
Revision as of 14:37, 17 May 2018
|
Post-streptococcal glomerulonephritis Microchapters |
|
Differentiating Post-streptococcal glomerulonephritis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Post-streptococcal glomerulonephritis primary prevention On the Web |
|
American Roentgen Ray Society Images of Post-streptococcal glomerulonephritis primary prevention |
|
FDA on Post-streptococcal glomerulonephritis primary prevention |
|
CDC on Post-streptococcal glomerulonephritis primary prevention |
|
Post-streptococcal glomerulonephritis primary prevention in the news |
|
Blogs on Post-streptococcal glomerulonephritis primary prevention |
|
Directions to Hospitals Treating Post-streptococcal glomerulonephritis |
|
Risk calculators and risk factors for Post-streptococcal glomerulonephritis primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Manpreet Kaur, MD [2]
Overview
Primary Prevention
- Effective measures for the primary prevention of post-streptococcal glomerulonephritis include:
- Improve hygiene
- Better housing
- Prevent overcrowding
- A 26-valent vaccine is recommended for children to prevent post-streptococcal glomerulonephritis.[1]
References
- ↑ Dale JB, Penfound T, Chiang EY, Long V, Shulman ST, Beall B (July 2005). "Multivalent group A streptococcal vaccine elicits bactericidal antibodies against variant M subtypes". Clin. Diagn. Lab. Immunol. 12 (7): 833–6. doi:10.1128/CDLI.12.7.833-836.2005. PMC 1182208. PMID 16002631.